Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100
Open accessAbstract
Abstract The metabolism of chylomicrons, very-low-density lipoprotein (VLDL), and their remnants in the postprandial state was studied in normolipidemic healthy men by measuring apoB-48 and apoB-100 and retinyl palmitate (RP) in fractions of triglyceride-rich lipoproteins after a mixed meal type of oral fat load supplemented with vitamin A. ApoB-48 was present at low concentrations in the fasting plasma samples in most subjects and increased in response to the test meal in Svedberg’s flotation rate (Sf) >20 lipoprotein fractions. Concomitantly, the level of Sf 60 to 400 apoB-100 (large VLDL) had doubled at 3 hours and returned to baseline at 9 hours. The number of apoB-48–containing lipoprotein particles did not exceed 20% of the total number of apoB-containing lipoproteins contained in Sf 12 to 400 fractions at any time point after fat intake. The peak plasma level of RP was delayed compared with the peak plasma concentration of apoB-48, suggesting that retinyl ester labeling of chylomicrons is questionable as a means of quantifying postprandial triglyceride-rich lipoproteins of intestinal origin. Approximately 2000 and 4000 RP molecules were carried in each chylomicron particle in the 3- and 6-hour samples, respectively, in contrast to the remnant fractions in which 100 to 600 RP molecules were found for each lipoprotein particle. The limited RP exchange between lipoprotein particles indicates that the smaller intestinal lipoproteins do no originate primarily from larger Sf >400 chylomicron particles but instead are secreted directly into the Sf 20 to 400 fraction and subsequently converted to smaller chylomicron remnants. This notion was further substantiated by injection of RP-labeled postprandial plasma into fasting subjects with subsequent tracing of RP in fractions of triglyceride-rich lipoproteins.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The concentration of VLDL cholesterol and apoB is at least 10 times higher than the corresponding chylomicron concentration, even after consumption of a large amount of fat.
“The concentration of VLDL cholesterol and apoB is at least 10 times higher than the corresponding chylomicron concentration, even after consumption of a large amount of fat (56 -59).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [57]
The Discussion (page unavailable) reports that VLDL accounts for more postprandial apoB-containing particles than chylomicrons and their remnants after a fat load. It does not establish that VLDL apoB is at least ten times higher, and the cited passages provide no corresponding cholesterol comparison. (LLM, conf=0.88)
Experimental — accuracy not yet measuredWhile approximately 80% of the rise in triglyceride levels after a fat-load meal is due to intestinally derived B48-containing lipoproteins, apoB100-containing VLDL account for most, approximately 80%, of the increase in particle number.
“While ∼80% of the rise in TG levels after a fat-load meal is due to intestinally derived B48-containing lipoproteins, apoB100-containing VLDL account for most (∼80%) of the increase in particle number”
Clinical recognition of postprandial hypertriglyceridaemia is hampered by technical difficulties and the lack of established clinical protocols for its characterization.
“Clinical recognition of postprandial hypertriglyceridaemia is hampered by technical difficulties and the lack of established clinical protocols for its characterization”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works
A new method for the direct determination of serum cholesterol.
Zlatkis, A., Zak, B., & Boyle, A. J. (1953) · PubMed · Cited by 2,465 · see citing works
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701 · see citing works
A colorimetric method for estimating serum triglycerides
Fletcher, M. J. (1968) · Clinica Chimica Acta · doi:10.1016/0009-8981(68)90041-7 · Cited by 1,138 · see citing works
Plasma triglyceride and coronary heart disease
Austin, M. A. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.1.2 · Cited by 697 · see citing works
Determination of serum triglycerides
Carlson, L. A. (1963) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(63)80012-5 · Cited by 694 · see citing works
Brunzell, J. D., Hazzard, W. R., Porte, D., & Bierman, E. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107334 · Cited by 484 · see citing works
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 420 · see citing works
Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113243 · Cited by 418 · see citing works
Weintraub, M. S., Zechner, R., Brown, A., Eisenberg, S., & Breslow, J. L. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113806 · Cited by 331 · see citing works
Weintraub, M. S., Eisenberg, S., & Breslow, J. L. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112926 · Cited by 261 · see citing works
Schneeman, B. O., Kotite, L., Todd, K., & Havel, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.2069 · Cited by 255 · see citing works
Cohn, J. S., Johnson, E. J., Millar, J. S., Cohn, S. D., Milne, R. W., Marcel, Y. L., Russell, R. M., & Schaefer, E. J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35345-1 · Cited by 248 · see citing works
Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Karpe, F., Steiner, G. A., Olivecrona, T., Carlson, L. A., & Hamsten, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116293 · Cited by 231 · see citing works
Self-citationPostprandial lipemia, fenofibrate and coronary artery disease
Simpson, H., Williamson, C., Olivecrona, T., Pringle, S., MacLean, J. A., Lorimer, A. R., Bonnefous, F., Bogaievsky, Y., Packard, C. J., & Shepherd, J. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90111-u · Cited by 229 · see citing works
Cohn, J. S., McNamara, J. R., Cohn, S. D., Ordovas, J. M., & Schaefer, E. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38485-6 · Cited by 195 · see citing works
Karpe, F., & Hamsten, A. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39974-0 · Cited by 182 · see citing works
Self-citationHazzard, W. R., & Bierman, E. L. (1976) · Metabolism · doi:10.1016/0026-0495(76)90149-9 · Cited by 169 · see citing works
Krasinski, S. D., Cohn, J. S., Russell, R. M., & Schaefer, E. J. (1990) · Metabolism · doi:10.1016/0026-0495(90)90249-c · Cited by 151 · see citing works
Rubinsztein, D. C., Cohen, J. C., Berger, G. M. B., van der Westhuyzen, D. R., Coetzee, G. A., & Gevers, W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114839 · Cited by 149 · see citing works
Intestinal absorption of vitamins A, E, D, and K.
Hollander, D. (1981) · PubMed · Cited by 146 · see citing works
Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
Berr, F., & Kern, F. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37744-0 · Cited by 132 · see citing works
Impaired chylomicron remnant clearance in familial combined hyperlipidemia.
Cabezas, M. C., de Bruin, T. W. A., Jansen, H., Kock, L. A., Kortlandt, W., & Erkelens, D. W. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.6.804 · Cited by 123 · see citing works
Wilson, D. E., Chan, I.-F., & Ball, M. (1983) · Metabolism · doi:10.1016/0026-0495(83)90016-1 · Cited by 67 · see citing works
Patsch, J. R. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80023-x · Cited by 56 · see citing works
Characterization of chylomicron remnant clearance by retinyl palmitate label in normal humans.
Berr, F. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41517-2 · Cited by 56 · see citing works
Postchallenge plasma lipoprotein retinoids: Chylomicron remnants in endogenous hypertriglyceridemia
Wilson, D. E., Chan, I.-F., Buchi, K. N., & Horton, S. C. (1985) · Metabolism · doi:10.1016/0026-0495(85)90193-3 · Cited by 51 · see citing works
Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families.
Sprecher, D. L., Knauer, S. L., Black, D. M., Kaplan, L. A., Akeson, A. A., Dusing, M. R., Lattier, D. L., Stein, E. A., Rymaszewski, M., & Wiginton, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115402 · Cited by 49 · see citing works
Ooi, T. C., Simo, I. E., & Yakichuk, J. A. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.10.1184 · Cited by 39 · see citing works
Baumstrak, M. W., Berg, A., Halle, M., & Keul, J. (1988) · Electrophoresis · doi:10.1002/elps.1150090918 · Cited by 24 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- Zilversmit DB. Atherosclerosis: a postprandial phenomenon. Circulation. 1979;60:473-485.
- Goodman DS. Vitamin A metabolism. Fed Proc. 1980;39:2716-2722.
- Diem K, Lentner C, eds. Documenta Geigy. 7th ed. Basel, Swit- zerland: JR Geigy SA; 1970:537.
- Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames, Iowa: Iowa State University Press; 1980.
- Blaner WS, Obunike JC, Kurlandsky SB, Al-Haideri M, Piantedosi R, Deckelbaum RJ, Goldberg IJ. Lipoprotein lipase hydrolysis of retinyl ester: possible implication for retinoid uptake of cells. J Biol Chem. 1994;369:16559-16565.
- Patsch J. Postprandial lipaemia. In: Shepherd J, ed. Bailliere's Clinical Endocrinology and Metabolism. Bailliere Tindall, London, England; 1987;1:551-580.
Cited by
Sorted by citations
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · see citing works
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979 · see citing works
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888 · see citing works
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., Sacks, F., Murad, M. H., & Stalenhoef, A. F. H. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3213 · Cited by 887 · see citing works
Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works
Chylomicrons promote intestinal absorption of lipopolysaccharides
Ghoshal, S., Witta, J., Zhong, J., de Villiers, W., & Eckhardt, E. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800156-jlr200 · Cited by 662 · see citing works
Pathophysiology of Diabetic Dyslipidemia
Hirano, T. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17023 · Cited by 552 · see citing works
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440 · see citing works
Postprandial lipoprotein metabolism and atherosclerosis.
Karpe, F. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00548.x · Cited by 360 · see citing works
Self-citationFreedman, D. S., Otvos, J. D., Jeyarajah, E. J., Barboriak, J. J., Anderson, A. J., & Walker, J. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1046 · Cited by 345 · see citing works
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315 · see citing works
Thomsen, C., Rasmussen, O., Lousen, T., Holst, J. J., Fenselau, S., Schrezenmeir, J., & Hermansen, K. (1999) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1135 · Cited by 319 · see citing works
Causes and consequences of hypertriglyceridemia
Packard, C. J., Boren, J., & Taskinen, M.-R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00252 · Cited by 239 · see citing works
Weintraub, M. S., Grosskopf, I., Rassin, T., Miller, H. I., Charach, G., Rotmensch, H. H., Liron, M., Rubinstein, A., & Iaina, A. (1996) · BMJ · doi:10.1136/bmj.312.7036.935 · Cited by 216 · see citing works
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor
Tenenbaum, A., Klempfner, R., & Fisman, E. Z. (2014) · Cardiovascular Diabetology · doi:10.1186/s12933-014-0159-y · Cited by 188 · see citing works
Sources of eicosanoid precursor fatty acid pools in tissues
Zhou, L., & Nilsson, Å. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32206-9 · Cited by 184 · see citing works
Apolipoprotein C-III: from pathophysiology to pharmacology
Norata, G. D., Tsimikas, S., Pirillo, A., & Catapano, A. L. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.001 · Cited by 182 · see citing works
Postprandial hypertriglyceridemia as a coronary risk factor
Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182 · see citing works
Methodology for studying postprandial lipid metabolism
Lairon, D., López‐Miranda, J., & Williams, C. M. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602749 · Cited by 159 · see citing works
Cohn, J. S., Marcoux, C., & Davignon, J. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2474 · Cited by 156 · see citing works
Mortensen, L. S., Hartvigsen, M. L., Brader, L., Astrup, A. V., Schrezenmeir, J., Holst, J. J., Thomsen, C., & Hermansen, K. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.27281 · Cited by 144 · see citing works
Postprandial lipoproteins and atherosclerosis
Kenneth, C.-W. Y. (2001) · Frontiers in bioscience · doi:10.2741/yu · Cited by 145 · see citing works
Gut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 126 · see citing works
Tholstrup, T., Sandström, B., Bysted, A., & Hølmer, G. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.198 · Cited by 120 · see citing works
Meyer, E., Westerveld, H. T., de Ruyter-Meijstek, F. C., van Greevenbroek, M. M. J., Rienks, R., van Rijn, H. J. M., Erkelens, D. W., & de Bruin, T. W. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05832-7 · Cited by 112 · see citing works
Karpe, F., Fairé, U. D., Mercuri, M. F., BOND, M., Hellénius, M.-L., & Hamsten, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00184-1 · Cited by 110 · see citing works
Self-citationPostprandial lipemia as a cardiometabolic risk factor
Pirillo, A., Norata, G. D., & Catapano, A. L. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.909394 · Cited by 108 · see citing works
Mamo, J. C. L., Proctor, S. D., & Smith, D. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00220-2 · Cited by 98 · see citing works
Karpe, F., Hellénius, M.-L., & Hamsten, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90076-8 · Cited by 97 · see citing works
Self-citationKinetics of plasma triglycerides in abdominal obesity
Björnson, E., Adiels, M., Taskinen, M., & Borén, J. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000375 · Cited by 94 · see citing works
TM6SF2 rs58542926 impacts lipid processing in liver and small intestine
O’Hare, E. A., Yang, R., Yerges‐Armstrong, L. M., Sreenivasan, U., McFarland, R. J., Leitch, C. C., Wilson, M. H., Narina, S., Gorden, A., Ryan, K. A., et al. (2016) · Hepatology · doi:10.1002/hep.29021 · Cited by 92 · see citing works
Jackson, K. G., Robertson, M. D., Fielding, B. A., Frayn, K. N., & Williams, C. M. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.5.942 · Cited by 92 · see citing works
Recent insights into factors affecting remnant lipoprotein uptake
Williams, K. J., & Chen, K. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328338cabc · Cited by 91 · see citing works
Triglyceride-rich lipoproteins and remnants: targets for therapy?
Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0745-6 · Cited by 90 · see citing works
Effect of variations in oral fat and carbohydrate load on postprandial lipemia
Jeppesen, J., Chen, Y. I., Zhou, M., Wang, T., & Reaven, G. M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1201 · Cited by 88 · see citing works
Silveira, A. M. V., Karpe, F., Johnsson, H., Bauer, K. A., & Hamsten, A. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.11.1333 · Cited by 88 · see citing works
Self-citationFasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Keirns, B. H., Sciarrillo, C. M., Koemel, N. A., & Emerson, S. R. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.73 · Cited by 86 · see citing works
Elevated triglyceride-rich lipoproteins in diabetes
Curtin, A., Deegan, P. B., Owens, D., Collins, P. B., Johnson, A., & TOMKIN, G. H. (1996) · Acta Diabetologica · doi:10.1007/bf02048544 · Cited by 86 · see citing works
Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics
Julve, J., Martín-Campos, J. M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.004 · Cited by 85 · see citing works
Tinker, L. F., Parks, E. J., Behr, S. R., Schneeman, B. O., & Davis, P. A. (1999) · Journal of Nutrition · doi:10.1093/jn/129.6.1126 · Cited by 83 · see citing works
Soedamah‐Muthu, S. S. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00428-8 · Cited by 82 · see citing works
Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
Xiang, S., Cianflone, K., Kalant, D., & Sniderman, A. D. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33411-8 · Cited by 81 · see citing works
Pal, S., Ellis, V., & Ho, S. S. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.032 · Cited by 80 · see citing works
Karpe, F., Olivecrona, T., Hamsten, A., & Hultin, M. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37219-9 · Cited by 80 · see citing works
Self-citationLevels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study
Freedman, D. S., Bowman, B. A., Otvos, J. D., Srinivasan, S. R., & Berenson, G. S. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00495-5 · Cited by 77 · see citing works
Chylomicron particle size and number, factor VII activation and dietary monounsaturated fatty acids
Silva, R., Kelly, C. N. M., Jones, A. E., Smith, R. D., Wootton, S. A., Miller, G. J., & Williams, C. M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00306-4 · Cited by 77 · see citing works
Hodson, L., Banerjee, R., Rial, B., Arlt, W., Adiels, M., Borén, J., Marinou, K., Fisher, C., Mostad, I. L., STRATTON, I. M., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002258 · Cited by 73 · see citing works
Self-citationHu, X., Jandacek, R. J., & White, W. S. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1170 · Cited by 73 · see citing works
Mortensen, L. S., Holmer-Jensen, J., Hartvigsen, M. L., Jensen, V. K., Astrup, A. V., de Vrese, M., Holst, J. J., Thomsen, C. E., & Hermansen, K. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2012.48 · Cited by 71 · see citing works
Karpe, F., & Hultin, M. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39742-x · Cited by 70 · see citing works
Self-citationWang, Y., Ghoshal, S., Ward, M. R., de Villiers, W. J. S., Woodward, J. G., & Eckhardt, E. R. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008442 · Cited by 68 · see citing works
Receptor-mediated mechanisms of lipoprotein remnant catabolism
Chappell, D. A., & Medh, J. D. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00017-4 · Cited by 68 · see citing works
Adiels, M., Matikainen, N., Westerbacka, J., Söderlund, S., Larsson, T. P., Olofsson, S., Borén, J., & Taskinen, M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.001 · Cited by 68 · see citing works
Holmer-Jensen, J., Mortensen, L. S., Astrup, A. V., de Vrese, M., Holst, J. J., Thomsen, C., & Hermansen, K. (2013) · Nutrition Research · doi:10.1016/j.nutres.2012.11.004 · Cited by 66 · see citing works
N-3 fatty acids and chylomicron metabolism in the rat
Harris, W. S., Hustvedt, B. E., Hagen, E., Green, M. H., Lu, G., & Drevon, C. A. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37258-8 · Cited by 64 · see citing works
Atorvastatin Improves Postprandial Lipoprotein Metabolism in Normolipidemic Subjects1
Parhofer, K. G., Barrett, P. H. R., & SCHWANDT, P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6978 · Cited by 65 · see citing works
Mattes, R. D. (2002) · Journal of Nutrition · doi:10.1093/jn/132.12.3656 · Cited by 65 · see citing works
Paetau, I., Chen, H., Goh, N., & White, W. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.5.1133 · Cited by 64 · see citing works
Campos, H., Khoo, C., & Sacks, F. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.045 · Cited by 58 · see citing works
Mero, N., Syvänne, M., Eliasson, B., Smith, U., & Taskinen, M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2096 · Cited by 59 · see citing works
Postprandial Remnant-like Lipoproteins in Hypertriglyceridemia1
Ooi, T. C., Cousins, M., Ooi, D. S., Steiner, G. A., Uffelman, K. D., Nakajima, K., & Simo, I. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7627 · Cited by 55 · see citing works
Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test
Tanaka, A., Tomie, N., Nakano, T., Nakajima, K., Yui, K., Tamura, M., & Numano, F. (1998) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00073-4 · Cited by 54 · see citing works
Postprandial Lipemia and Remnant Lipoproteins
Cohn, J. S. (2006) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2006.07.003 · Cited by 54 · see citing works
Wang, Y., Ghoshal, S., Ward, M. R., de Villiers, W. J. S., Woodward, J. G., & Eckhardt, E. R. M. (2010) · PLoS ONE · doi:10.1371/annotation/bc95caf3-62cf-4ecd-8a79-9116e62f4a50 · Cited by 54 · see citing works
Obesity and post-prandial lipid metabolism. Feast or famine?
Martins, I. J., & Redgrave, T. G. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2003.10.006 · Cited by 51 · see citing works
Treatment options for hypertriglyceridemia: From risk reduction to pancreatitis
Berglund, L., Brunzell, J. D., Goldberg, A. C., Goldberg, I. J., & Stalenhoef, A. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.002 · Cited by 50 · see citing works
Lemieux, S., Fontani, R., Uffelman, K. D., Lewis, G. F., & Steiner, G. A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32494-9 · Cited by 49 · see citing works
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Clinical Science · doi:10.1042/cs20040108 · Cited by 48 · see citing works
The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia
Wu, X., Chen, K., & Williams, K. J. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283544424 · Cited by 47 · see citing works
Postprandial lipid metabolism in relation to coronary heart disease
Karpe, F. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970067 · Cited by 47 · see citing works
Self-citationBjörnson, E., Packard, C. J., Adiels, M., Andersson, L., Matikainen, N., Söderlund, S., Kahri, J., Hakkarainen, A., Lundbom, N., Lundbom, J., et al. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13017 · Cited by 46 · see citing works
Guerci, B., Vergès, B. L., Durlach, V., Hadjadj, S., Drouin, P., & Paul, J. L. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801181 · Cited by 46 · see citing works
Difference in effect of myristic and stearic acid on plasma HDL cholesterol within 24 h in young men
Tholstrup, T., Vessby, B., & Sandström, B. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601605 · Cited by 46 · see citing works
Familial hypercholesterolemia and triglyceride metabolism
Kolovou, G. D., Kostakou, P. M., & Anagnostopoulou, K. K. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.08.009 · Cited by 42 · see citing works
Couillard, C., Bergeron, N., Pascot, A., Alméras, N., Bergeron, J., Tremblay, A., Prud’homme, D., & Després, J. (2002) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.2.311 · Cited by 41 · see citing works
Severe hypertriglyceridemia: Existing and emerging therapies
Malick, W. A., Do, R., & Rosenson, R. S. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108544 · Cited by 44 · see citing works
Dallongeville, J., Tiret, L., Visvikis‐Siest, S., O’Reilly, D. S. J., Saava, M., Tsitouris, G., Rosseneu, M., DeBacker, G., Humphries, S. E., & Beisiegel†, U. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00069-6 · Cited by 40 · see citing works
Mero, N., Suurinkeroinen, L., Syvänne, M., Knudsen, P., Yki‐Järvinen, H., & Taskinen, M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33412-x · Cited by 38 · see citing works
Hayashi, T., Hirano, T., Yamamoto, T., Ito, Y., & Adachi, M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.014 · Cited by 37 · see citing works
Rodrı́guez-Villar, C., Manzanares, J. M., Casals, E., Pérez-Heras, A., Zambón, D., Gomis, R., & Ros, E. (2000) · Metabolism · doi:10.1053/meta.2000.18573 · Cited by 37 · see citing works
The Elevation of Ingested Lipids within Plasma Chylomicrons Is Prolonged in Men Compared with Women
Knuth, N. D., & Horowitz, J. F. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.6.1498 · Cited by 36 · see citing works
Pedersen, A. T., Marckmann, P., & Sandström, B. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599001245 · Cited by 36 · see citing works
Talmud, P. J., Hall, S., Holleran, S., Ramakrishnan, R., Ginsberg, H. N., & Humphries, S. E. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32543-8 · Cited by 36 · see citing works
Verseijden, C., Meijssen, S., van Dijk, H., Jansen, H., & Cabezas, M. C. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300201-jlr200 · Cited by 35 · see citing works
Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans
Karpe, F., Humphreys, S. M., Samra, J. S., Summers, L. K. M., & Frayn, K. N. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34947-6 · Cited by 35 · see citing works
Self-citationVine, D. F., Glimm, D. R., & Proctor, S. D. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.004 · Cited by 34 · see citing works
Su, J. W., Nzekwu, M. M. U., Cabezas, M. C., Redgrave, T. G., & Proctor, S. D. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02179.x · Cited by 33 · see citing works
Verseijden, C., Meijssen, S., & Cabezas, M. C. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30169-3 · Cited by 33 · see citing works
Ylitalo, K., Pajukanta, P., Meri, S., Cantor, R. M., Matikainen, N., Vakkilainen, J., Nuotio, I. O., & Taskinen, M. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.5.838 · Cited by 33 · see citing works
Clearance of postprandial lipoproteins in normolipemics: role of the apolipoprotein E phenotype
Orth, M., Wahl, S., Hanisch, M., Friedrich, I., Wieland, H., & Luley, C. H. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00075-6 · Cited by 33 · see citing works
Holmer-Jensen, J., Hartvigsen, M. L., Mortensen, L. S., Astrup, A. V., de Vrese, M., Holst, J. J., Thomsen, C. E., & Hermansen, K. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.142 · Cited by 31 · see citing works
Triacylglycerol Fatty Acid Positional Distribution and Postprandial Lipid Metabolism
Linderborg, K. M., & Kallio, H. P. T. (2005) · Food Reviews International · doi:10.1080/fri-200061623 · Cited by 30 · see citing works
Björkegren, J., Silveira, A. M. V., Boquist, S., Tang, R., Karpe, F., Bond, M. G., Fairé, U. D., & Hamsten, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000029972.42487.42 · Cited by 29 · see citing works
Self-citationIS ATHEROSCLEROSIS EXCLUSIVELY A POSTPRANDIAL PHENOMENON?
Mamo, J. C. L., Yu, K. C., Elsegood, C. L., Smith, D., Vine, D. F., Gennat, H. C., Voevodin, M., & Proctor, S. D. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb01822.x · Cited by 28 · see citing works
The acylation-stimulating protein pathway and regulation of postprandial metabolism
Sniderman, A. D., Cianflone, K., Summers, L. K. M., Fielding, B. A., & Frayn, K. N. (1997) · Proceedings of The Nutrition Society · doi:10.1079/pns19970070 · Cited by 28 · see citing works
A low temperature flotation method to rapidly isolate lipoproteins from plasma
Tong, H., Knapp, H. R., & VanRollins, M. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32200-8 · Cited by 27 · see citing works
Kovář, J., & Havel, R. J. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100435-jlr200 · Cited by 24 · see citing works
Jackson, K. G., & Williams, C. M. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.003 · Cited by 24 · see citing works
Tremblay, A. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.011 · Cited by 24 · see citing works
Jackson, K. G., Zampelas, A., Knapper, J. M. E., Culverwell, C. C., Wright, J., GOULD, B. J., & Williams, C. M. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599000148 · Cited by 24 · see citing works
- Authors
- Karpe, F., Bell, M., Björkegren, J., & Hamsten, A.
- Affiliations
- Karolinska University Hospital (SE)
- From the Atherosclerosis Research Unit, King Gustaf V Research Institute, Department of Medicine, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1995-02
- Volume
- 15
- Issue
- 2
- Pages
- 199-207
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2107863042
- Cited by
- 143
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 4 · 2013: 6 · 2012: 4
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hjärt-Lungfonden
- Marcus och Amalia Wallenbergs minnesfond
- Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- postprandial lipemia, triglyceride-rich lipoproteins, chylomicrons, VLDL, apolipoprotein B-48, apolipoprotein B-100, chylomicron remnants, vitamin A, lipoprotein metabolism
- MeSH terms
- Retinyl Esters, Adult, Apolipoproteins B, Chylomicrons, Dietary Fats, Diterpenes, Eating, Fasting, Humans, Male, Triglycerides, Vitamin A, Apolipoprotein B-48, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
